They are shaping how clearly we see disease, guide treatment, and protect patient safety. As next-generation agents promise lower gadolinium exposure and evolving guidelines reshape best practice, radiology teams face an important moment of transition.
Real-world gaps in training, confidence, and decision-making can limit the safe and effective use of these powerful tools. This program explores what’s changing, what matters most, and how to translate emerging evidence into confident clinical practice—helping you optimize contrast selection, dosing, and patient care in a rapidly advancing field.
This program is for radiologists, neuroradiologists, radiographers, MRI physicians, and imaging technologists. It is also suitable for neurologists and cardiologists.
Dr. Àlex Rovira is a full-time neuroradiologist who received his MD from the Autonomous University of Barcelona in 1983 and completed his radiology residency at Vall d’Hebron University Hospital. After a visiting fellowship at Shands Hospital, University of Florida, in 1989, he joined the Neuroradiology Section at Vall d’Hebron Hospital in 1990. His clinical and research interests focus on diagnostic neuroradiology and head and neck radiology, particularly demyelinating and neurodegenerative diseases.
He is Director of the Neuroradiology Section at Vall d’Hebron University Hospital. He currently serves as Chair of the Referral Guidelines Subcommittee of the ESR, Chair of the ESNR Green Committee, and President-Elect of the ESMRMB. He is also a member of MAGNIMS and serves on the editorial boards of Neurology and the Canadian Association of Radiologists Journal.
He is an Honorary Lecturer at University College London.
Dr. Rovira has authored more than 620 scientific publications (h-index 89), contributed 30 book chapters, and delivered over 500 invited lectures. His research has significantly advanced the use of MRI as a biomarker in neurological disorders, particularly autoimmune diseases of the central nervous system. He has received several recognitions, including research excellence awards from the Barcelona Medical Council (2016) and the Spanish Society of Radiology (2025).
Dr. Àlex Rovira has participated in company sponsored speaker bureaus for Bayer, Sanofi, Merck, Teva Pharmaceutical Industries Ltd, Novartis, Roche, BMS, Neuroaxpharm, Biogen.
Carlo C. Quattrocchi is Professor of Diagnostic Imaging and Neuroradiology at the University of Trento. For the last 10 years the main interests of research and education have focused on safety of contrast media and indications and appropriateness of gadolinium-based contrast agents in radiology. He is co-chair of the ESMRMB-GREC working group and member of the Contrast Media Safety Committee of the European Society of Urogenital Radiology.
Ad hoc Consultant/Speaker for events organized by Bayer, Bracco, GE HealthCare, Guerbet
Unconditional support of ESMRMB-GREC working group meetings by Bayer, Bracco, GE HealthCare, Guerbet
Unconditional support of ESUR-Contrast Media Safety committee by Bayer, Bracco, GE HealthCare, Guerbet
Dr. Giles Roditi is a consultant cardiovascular radiologist in NHS Greater Glasgow & Clyde. He is also an Honorary Clinical Associate Professor of Radiology at the University of Glasgow. Dr. Roditi first became involved with cardiac MRI during training in Aberdeen in 1993 and gained further experience in CMR techniques as visiting Fellow at Harvard University, Boston in 1994. He has worked at Glasgow Royal Infirmary since 1997, with particular interests in cardiac MRI, cardiac CTA, renovascular imaging, lower limb MRA techniques, carotid MRA and venous imaging. Dr Roditi is a past-President of the British Society of Cardiovascular Imaging, past-Chair for Contrast Procurement in Scotland & Northern Ireland and has also been involved with the RCR Standards for Intravascular Contrast Administration to Adult Patients.
Giles Roditi discloses honoraria and/or consultation fees from Bayer AG and Bracco SpA.
Minerva Becker is Professor of Radiology and Head of the Imaging Unit of Head and Neck and Maxillofacial Radiology, Diagnostic Department, at the University Hospitals of Geneva.
Professor Becker’s clinical expertise and main fields of research include head and neck and maxillo-facial imaging. Her track record is mainly in head and neck oncology research including hybrid and multiparametric imaging, and texture analysis towards a personalized treatment approach. Further research fields include imaging of the salivary glands, orbit, and skull base.
Professor Becker has received over 30 international and national scientific awards and prizes and has obtained several research grants supported by the Swiss National Science Foundation. She is the author of over 200 scientific publications and is a co-editor of Valvassouri’s Head and Neck Imaging. She is a reviewer for numerous international scientific journals and participates equally as an external expert in international and national juries for university nominations and promotions.
Professor Becker is an enthusiastic teacher with over 350 invited lectures at international and national meetings and was awarded the 2015 ESOR Best Teacher Award. As Chair of the Education Committee of the European Society of Head and Neck Radiology (ESHNR), she oversaw the European training curriculum and subspecialty diploma in head and neck radiology. She is the Past-President of the ESHNR and an honorary member of the European Laryngological Society.
Between March 2021 and July 2023, Professor Becker served as Chair of the Education Committee of the European Society of Radiology (ESR)
Prof Minerva Becker has no interests to disclose.
Dr. Kottler has been a practicing radiologist specializing in emergency imaging for over 20 years. Combining her clinical experience with a graduate degree in applied mathematics, she has been using technological innovation to drive value in radiology. As the first radiologist to join Radiology Partners, Dr. Kottler has held multiple leadership positions within her practice and is currently the associate Chief Medical Officer for Clinical AI. Dr. Kottler is also an associate fellow at the Stanford AIMI Center and serves on committees for RSNA, ACR, RADequal, and SIIM. Dr. Kottler is passionate about promoting diversity and creating a culture of belonging. As an industry expert, Dr. Kottler has consulted for companies in aerospace, materials science, and healthcare and is a frequent international lecturer discussing imaging AI. In 2025, Dr. Kottler received the Dr. Ruth Dayhoff award for the advancement of women in medical imaging informatics, and was highlighted as a chief AI officer to know and a radiology key opinion leader.
Nina Kottler declares stocks, shares, or/and equity in Radiology Partners, aidoc, and Rad AI
